THE PROSPECTS OF THE COMBINED TREATMENT OF NON-SMALL CELL LUNGCANCER SPREAD FORMS

  • Akhat Bukenov Department of Oncology, Karaganda State Medical University, 40 Gogol Street, Karaganda 100000, Kazakhstan, gera-bek@bk.ru; and Department of Chest Surgery, Karaganda Cancer Hospital, 189 Kryvoguza Street, Karaganda 100000, Kazakhstan, kooc@mail.ru
  • Elena Gizbrekht Department of Oncology, Karaganda State Medical University, 40 Gogol Street, Karaganda 100000, Kazakhstan, gera-bek@bk.ru; and Department of Chest Surgery, Karaganda Cancer Hospital, 189 Kryvoguza Street, Karaganda 100000, Kazakhstan, kooc@mail.ru
  • Ergaly Shauenov Department of Oncology, Karaganda State Medical University, 40 Gogol Street, Karaganda 100000, Kazakhstan, gera-bek@bk.ru; and Department of Chest Surgery, Karaganda Cancer Hospital, 189 Kryvoguza Street, Karaganda 100000, Kazakhstan, kooc@mail.ru
  • Bekzhan Orazbayev Department of Oncology, Karaganda State Medical University, 40 Gogol Street, Karaganda 100000, Kazakhstan, gera-bek@bk.ru; and Department of Chest Surgery, Karaganda Cancer Hospital, 189 Kryvoguza Street, Karaganda 100000, Kazakhstan, kooc@mail.ru
  • Kalmurat Razzakov Department of Oncology, Karaganda State Medical University, 40 Gogol Street, Karaganda 100000, Kazakhstan, gera-bek@bk.ru; and Department of Chest Surgery, Karaganda Cancer Hospital, 189 Kryvoguza Street, Karaganda 100000, Kazakhstan, kooc@mail.ru
Keywords: Non-Small-Cell Lung Cancer, Combined Treatment, Arglabyn Radio Sensibilization, Neoadjuvant Chemotherapy, Radiation Therapy

Abstract

The Purpose of this study is to demonstrate the effectiveness of combined treatment for III A-B stage of non-small-cell lung cancer. Non-small-cell lung cancer spread form treatment is disputable. Operation is not final solution. The combined treatment is being tested (in clinical trials) in this study. This article argues that a combination of treatment is a better option than that of a specific treatment. However, there is a need to find new effective options for combined treatment.

References

Arroliga, A.C.,Malthay, R.A. (1993). The role of bronchoscope in lung cancer.Clinical Chest Medicine, 14, 87-98.

Artemova, N.A., Minaylo,I.I. (2012). Non-small-cell lung carcinoma stage and radiation-inducted tumor involution are as survival prognosis factor.VII International congress of Oncologists and Radiologists of CIS countries.Astana, 215.

Dobrodiev, A.U., Buzinov, C.A., Zavyalow, A.U. (2012). Lung cancer combined treatment and intraoperative radiation therapy. VII International congress of Oncologists and Radiologists of CIS countries.Astana, 220.

Machtay, B.M., Lee, J.H. (2001). Risk of death from concurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. Clinical Oncology, 19, 3912-3917.

Miller, S.B., Tuzicov, S.A., Goldberg, W.E.(2012). Non-small-cell cancer patients neo-adjuvant chemotherapy.VII International congress of Oncologists and Radiologists of CIS countries.Astana, 228.

Rice, T.W., Adelstein, D.J., Koka, A. (1995). Radiation induction therapy and resection for poor prognosis III stagenon-small-cell lung cancer.ThoracicSurgery, 60, 586-591.

Published
2014-05-01
Section
Articles